HOME >> MEDICINE >> NEWS
Mayo Clinic researchers create 'obedient virus'; First step to use measles virus against cancer

ROCHESTER, Minn. -- An international team of Mayo Clinic-led researchers is first to devise a system that consistently converts the measles virus into a therapeutic killer that hunts down and destroys cancer cells -- and cancer cells only. Their research findings appear in the current issue of Nature Biotechnology http://www.nature.com/nbt/.

The researchers harnessed the viral trait for attacking and commandeering cells, and then redirected the virus to attack diseased, rather than healthy cells. The work was done on laboratory animals implanted with two kinds of human cancer cells -- ovarian cancer and lymphoma -- and is probably still years away from use as a human therapy. But the concept has at last been proved in mice with human cancer tumors -- and that's an essential step toward using this approach to expand and improve human treatments for a variety of cancers.

The "Obedient Virus"

"When I saw the data, I was completely stunned. It's the sort of thing that, having worked on targeting viruses for about 15 years, I just couldn't believe that we'd finally got what we'd been hunting all that time," says Stephen Russell, M.D., Ph.D., lead researcher and director of Mayo Clinic's Molecular Medicine Program.

"It's very clean, very clear targeting. Our results show that we've efficiently ablated (destroyed) the ability of the measles virus to interact with its two natural receptors. And they also show that we can take our pick as to what new receptor we target and send the virus after it."

How They Did It

Using bioengineering techniques, the team reprogrammed the measles virus to seek a cancer cell to bind to instead of its natural binding partner. Then they invented a "molecular tag" that they attached to structures on the outside of the cancer-seeking measles virus. This tag is the key innovation of their work and central to the success of the team's investi
'"/>

Contact: Bob Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
2-Feb-2005


Page: 1 2

Related medicine news :

1. Mayo Clinic discovers new pathway against pancreatic cancer
2. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
3. Mayo Clinic study sets threshold for valve repair surgery
4. Mayo Clinic researcher calls for improved newborn screening
5. Mayo Clinic study finds obese kidney donors face few increased risks
6. Mayo Clinic identifies key cellular process in prostate and other cancers
7. Clinical breast examination offers modest benefit to breast cancer screening program
8. Clinicians report missing patient information is common
9. Mayo Clinic discovers a key to low metabolism and major factor in obesity
10. Clinical trial of Etanercept for Wegeners disease shows no benefit
11. Mayo Clinic researchers identify new form of muscular dystrophy in adults

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2019)... ... 2019 , ... Pennsylvania College of Health Sciences, the area’s ... the fourth quarter of the 2018-2019 academic year, the school’s NCLEX scores continue ... College’s annual pass rate for the 2018-2019 academic year was 95.02%, maintaining the ...
(Date:11/7/2019)... ... ... Atlantic Ultraviolet Corporation makes it their business to fight the flu. The first ... season starts in October until March, Atlantic Ultraviolet makes it a point to host ... get their shot. , Ann Wysocki, COO of Atlantic Ultraviolet Corporation® says, “Atlantic Ultraviolet ...
(Date:11/7/2019)... SAN FRANCISCO (PRWEB) , ... November 07, 2019 , ... ... available in select southern markets. The product line includes a 4 and a 7 ... that [can] transmit diseases, such as Zika, West Nile Virus and Encephalitis, without exposing ...
(Date:11/7/2019)... ... November 07, 2019 , ... ... of Ignite and Expand got together on the Shamangelic Healing Podcast ... downloads skyrocketed. With a trending focus on learning ways to use bio-hacking to ...
(Date:11/6/2019)... Ky., and CENTENNIAL, Colo. (PRWEB) , ... November ... ... intelligence and consumer research platform, and the University of Kentucky Research Foundation (UKRF) ... of hemp-derived products. The agreement will give hemp-derived product companies access to the ...
Breaking Medicine News(10 mins):
(Date:11/5/2019)... MONTCLAIR, N.J. (PRWEB) , ... November 05, 2019 ... ... San Antonio, 555 South Alamo Street in Texas will be a timely program ... instruction in the management of chronic pain. , The Texas Medical Board requires ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... Nov. 13-14: How to Build a Sponsor Risk Management Program, Friday, Nov. ... Wednesday-Friday, Nov. 13-15, 2019 • Philadelphia, PA , https://www.fdanews.com/cwiche6gcp , ...
(Date:11/4/2019)... ... ... E-Z-C Pak Creator Dr. Sarath Malepati reeled in famed entrepreneur ... Shark Tank on ABC. EZC Pak is a physician formulated immune support pack composed ... use in colds and flu. , Dr. Malepati negotiated a $125,000 investment for a ...
Breaking Medicine Technology:
Cached News: